Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Keratosis, Actinic 1

Interventions

Aminolevulinic Acid 5Fluorouracil 3tirbanibulin 2Photochemotherapy 2Niacinamide 2Cryotherapy 2methyl 5-aminolevulinate 1green tea extract polyphenone E 1dehydroftorafur 1calcipotriene 1Therapeutics 1Sunscreening Agents 1Powders 1Ointments 1Imipramine 1Control Groups 1Biopsy 1BF-200 ALA 1Aluminum Chloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Keratosis, Actinic × BF-200 ALA × 1 year × Clear all
NCT05662202 2026-05-22

Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp

Biofrontera Inc.

Phase 3 Active not recruiting
172 enrolled
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡